Company UpdateNewspaper Publication
HealthcarePharmaceuticals & BiotechnologyPharmaceuticals
Kerala Ayurveda Ltd
Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 43 filings·Updated 13 Aug 2026
Showing 10 of 43 filings.
13 Aug 20261 filing
12 Aug 20262 filings
Company UpdatePress Release / Media Release
Kerala Ayurveda reiterates path to Rs 1,000 Cr revenue by FY30; Q1 FY27 shows narrower EBITDA loss
Q1 FY27 highlights
- Consolidated revenue Rs 33.19 Cr, +16.0% YoY.
- Standalone revenue Rs 22.53 Cr, +28.3% YoY.
- Operating EBITDA (Adj.) loss Rs 3.82 Cr; QoQ improvement ~50%.
- PBT Rs -8.23 Cr; PAT Rs 8.08 Cr (YoY includes land sale gain).
- Global E-Product +32.3% YoY; India D2C +38.9% YoY.
- EBITDA improvement driven by margins, disciplined marketing, lower staff costs, tighter overheads.
Strategic and operational plan
- Vision 2030 target: Rs 1,000 Cr revenue by FY30.
- Open clinics in San Jose, Eindhoven, and India by Nov 2026.
- Karwar Health Village opens Oct 2026; Costa Rica Ayurvedagram Jan 2027.
- New premium Ayurveda brand to launch in Nov 2026.
- ERP-Next rollout to begin Oct 2026 for real-time visibility.
Outlook and capital structure
- Promoter loans conversion to equity planned in H2 FY27 to ease interest burden.
- Management confident of achieving all three Vision 2030 milestones.
- PBT negative due to higher promoter loan interest; prior-year land sale gain affected PAT.
ResultFinancial Results
Kerala Ayurveda Board approves Q1 2026 unaudited results, amalgamation with Ayurvedagram, ESOP grant, director re-appointment
Key disclosures
- Quarter ended June 30, 2026: unaudited standalone and consolidated results with unmodified limited review.
- Scheme of Amalgamation with Ayurvedagram Heritage Wellness Centre Private Limited approved, subject to shareholder and NCLT approvals.
- Ramesh Vangal re-appointment as Non-Executive Director; appointment at ensuing AGM.
- AGM scheduled for September 28, 2026.
- NRC approved 64,875 ESOPs under Kerala Ayurveda Employee RSU Plan 2023; exercise price Rs 10.
- Limited Review Report by Statutory Auditors issued with unmodified opinion.
- No change in shareholding pattern post-amalgamation.
- Transferor Ayurvedagram turnover Rs 1546.69 Lakhs; PAT Rs 316.16; net worth Rs 1622.79.
- Transferee Kerala Ayurveda turnover Rs 8548.49 Lakhs; PAT Rs -1474.12; net worth Rs 3614.78.
3 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Reg 74(5) certificate confirms dematerialisation and listing for the reporting quarter
Dematerialisation/rematerialisation status
- Securities received for dematerialisation in the reporting quarter have been dematerialised and listed.
- Physical certificates received for dematerialisation were mutilated and cancelled after verification.
- The depository name has been substituted as registered owner within 15 days.
24 Jun 20261 filing
Company UpdateNewspaper Publication
News paper publication
9 Jun 20263 filings
Company UpdateChange in Management
Kerala Ayurveda Ltd - 530163 - Announcement under Regulation 30 (LODR)-Change in Management
Independent director resignation
- Mr. Samir Dhawan Agarwal resigned as Independent Director, effective close of business on June 9, 2026.
- Reason cited: other professional commitments requiring increased time and attention.
- He confirmed there were no other material reasons for resignation.
- No listed-entity directorships or committee memberships were reported.
- No board or committee composition impact was stated.
Company UpdateGeneral
Intimation under regulation 30(5)
Company UpdateChange in Management
Kerala Ayurveda Ltd - 530163 - Announcement under Regulation 30 (LODR)-Change in Management
Company secretary appointment
- Mr. Binu Thomas appointed Company Secretary and Compliance Officer, effective 9 June 2026.
- Board approved the appointment at its meeting on 9 June 2026.
- He is an ICSI Fellow Member with MBA, GST diploma, and over 10 years' experience.
- Previously served as Company Secretary and Compliance Officer at Harrisons Malayalam Limited.
- No director relationship disclosure was applicable.
30 May 20261 filing
Company UpdateReg.24(A)-Annual Secretarial Compliance
ASCR 2026
26 Mar 20261 filing
Insider Trading / SASTClosure of Trading Window
Closure of Trading window
Showing 10 of 43 filings